4000 Series Controlled Rate Chamber: Innovative Freezer Technology Revolutionizes Biologic Drug Handling

News
Article

Sponsored Content

The significant growth of the biologic drug market, bolstered by the COVID-19 pandemic and the development of relevant vaccines, along with the growing complexity and fragility of biologic drugs, has led to a need for improved freezing and thawing methods. While biologic drugs are becoming more mainstream as the pharmaceutical industry focuses on their development, maintaining high yields becomes critical to enabling timely introduction to the market and ensuring sufficient supplies. New technology exists that can help ensure higher yields and help meet demand timelines. Check out this white paper to learn more.

Related Content
© 2024 MJH Life Sciences

All rights reserved.